Invivyd, Inc. (IVVD)
0.9494
-0.02
(-1.57%)
USD |
NASDAQ |
Aug 31, 14:43
Invivyd Total Liabilities (Quarterly) : 37.80M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 37.80M |
| March 31, 2026 | 38.69M |
| December 31, 2025 | 35.34M |
| September 30, 2025 | 46.09M |
| June 30, 2025 | 46.35M |
| March 31, 2025 | 49.60M |
| December 31, 2024 | 61.98M |
| September 30, 2024 | 78.76M |
| June 30, 2024 | 36.70M |
| March 31, 2024 | 36.97M |
| December 31, 2023 | 51.71M |
| September 30, 2023 | 28.42M |
| Date | Value |
|---|---|
| June 30, 2023 | 33.85M |
| March 31, 2023 | 23.82M |
| December 31, 2022 | 27.20M |
| September 30, 2022 | 47.30M |
| June 30, 2022 | 69.77M |
| March 31, 2022 | 96.88M |
| December 31, 2021 | 62.07M |
| September 30, 2021 | 53.06M |
| June 30, 2021 | 37.90M |
| March 31, 2021 | 28.69M |
| December 31, 2020 | 13.08M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 218.88M |
| Shareholders Equity (Quarterly) | 181.08M |
| Debt to Equity Ratio | 0.0463 |
| Current Ratio | 5.869 |
| Net Debt Paydown Yield | -0.58% |